[Benzodiazepines: pharmacodynamic aspects].
Jacqmin
P
P
Lesne
M
M
D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology*; D000927:Anticonvulsants; D001007:Anxiety / Q000188:drug therapy; D001341:Autonomic Nervous System / Q000187:drug effects; D001569:Benzodiazepines; D006801:Humans; D008568:Memory / Q000187:drug effects; D008970:Molecular Weight; D009125:Muscle Relaxants, Central; D018377:Neurotransmitter Agents / Q000378:metabolism; D011963:Receptors, GABA-A / Q000378:metabolism; D012890:Sleep / Q000187:drug effects
D014151:Anti-Anxiety Agents; D000927:Anticonvulsants; D009125:Muscle Relaxants, Central; D018377:Neurotransmitter Agents; D011963:Receptors, GABA-A; D001569:Benzodiazepines
Les benzodiazepines: aspects pharmacodynamiques.